Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cell Stem Cell. 2007 Nov;1(5):497-501.

Evaluating therapeutic efficacy against cancer stem cells: new challenges posed by a new paradigm.

Author information

  • Division of Cell and Molecular Biology, Toronto General Research Institute, Toronto, ON M5G 1L7, Canada. jwang@uhnres.utoronto.ca

Abstract

Current measures of anticancer drug efficacy reflect bulk cell killing and are poorly suited to detect activity against cancer stem cells (CSCs), which sustain tumor growth. The CSC paradigm necessitates a reexamination of methodologies used to evaluate clinical efficacy of anticancer therapies, as well as strategies employed during preclinical drug development.

PMID:
18938746
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk